Freezing of gait in Parkinson's disease: from pathophysiology to emerging therapies

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Giladi N, Nieuwboer A. Understanding and treating freezing of gait in parkinsonism, proposed working definition, and setting the stage. Mov. Disord. 23(Suppl. 2), S423–S425 (2008).
  MedlineGoogle Scholar
• 2 Fahn S. The freezing phenomenon in parkinsonism. Adv. Neurol. 67, 53–63 (1995).
  Medline CASGoogle Scholar
• 3 Schaafsma JD, Balash Y, Gurevich T, Bartels AL, Hausdorff JM, Giladi N. Characterization of freezing of gait subtypes and the response of each to levodopa in Parkinson's disease. Eur. J. Neurol. 10(4), 391–398 (2003).
  Medline CASGoogle Scholar
• 4 Giladi N, Shabtai H, Simon ES, Biran S, Tal J, Korczyn AD. Construction of freezing of gait questionnaire for patients with Parkinsonism. Parkinsonism. Relat. Disord. 6(3), 165–170 (2000).
  Medline CASGoogle Scholar
• 5 Giladi N, Kao R, Fahn S. Freezing phenomenon in patients with parkinsonian syndromes. Mov. Disord. 12(3), 302–305 (1997).
  Medline CASGoogle Scholar
• 6 Giladi N, Mcmahon D, Przedborski S et al. Motor blocks in Parkinson's disease. Neurology 42(2), 333–339 (1992).
  Medline CASGoogle Scholar
• 7 Jankovic J. Gait disorders. Neurol. Clin. 33(1), 249–268 (2015).
  MedlineGoogle Scholar
• 8 Lee MS, Lyoo CH, Choi YH. Primary progressive freezing gait in a patient with CO-induced parkinsonism. Mov. Disord. 25(10), 1513–1515 (2010).
  MedlineGoogle Scholar
• 9 Hogarth P. Neurodegeneration with brain iron accumulation: diagnosis and management. J. Mov. Disord. 8(1), 1–13 (2015).
  MedlineGoogle Scholar
• 10 Wong JC, Armstrong MJ, Lang AE, Hazrati LN. Clinicopathological review of pallidonigroluysian atrophy. Mov. Disord. 28(3), 274–281 (2013).
  MedlineGoogle Scholar
• 11 Nutt JG, Bloem BR, Giladi N, Hallett M, Horak FB, Nieuwboer A. Freezing of gait: moving forward on a mysterious clinical phenomenon. Lancet Neurol. 10(8), 734–744 (2011).
  MedlineGoogle Scholar
• 12 Kuo SH, Kenney C, Jankovic J. Bilateral pedunculopontine nuclei strokes presenting as freezing of gait. Mov. Disord. 23(4), 616–619 (2008).
  MedlineGoogle Scholar
• 13 Nakajima A, Ueno Y, Shimura H et al. Acute transient freezing of gait in a patient with posterior reversible encephalopathy syndrome. BMC Neurol. 13, 79 (2013).
  MedlineGoogle Scholar
• 14 Okuma Y. Freezing of gait and falls in Parkinson's disease. J. Parkinsons. Dis. 4(2), 255–260 (2014).
  MedlineGoogle Scholar
• 15 Julia VR, Roberta B, Angelo A. Therapy-resistant symptoms in Parkinson's disease. J. Neural. Transm. 123(1), 19–30 (2015).
  MedlineGoogle Scholar
• 16 Okuma Y, Yanagisawa N. The clinical spectrum of freezing of gait in Parkinson's disease. Mov. Disord. 23(Suppl. 2), S426–S430 (2008).
  MedlineGoogle Scholar
• 17 Nieuwboer A. Cueing for freezing of gait in patients with Parkinson's disease: a rehabilitation perspective. Mov. Disord. 23(Suppl. 2), S475–S481 (2008).
  MedlineGoogle Scholar
• 18 Ehgoetz Martens KA, Ellard CG, Almeida QJ. Does anxiety cause freezing of gait in Parkinson's disease? PLoS ONE 9(9), e106561 (2014).
  MedlineGoogle Scholar
• 19 Bloem BR, Hausdorff JM, Visser JE, Giladi N. Falls and freezing of gait in Parkinson's disease: a review of two interconnected, episodic phenomena. Mov. Disord. 19(8), 871–884 (2004). • Valuable paper providing an accessible and wide overview on the complexity of the phenomenon as well as on its relationship with falls.
  MedlineGoogle Scholar
• 20 Giladi N, Mcdermott MP, Fahn S et al. Freezing of gait in PD: prospective assessment in the DATATOP cohort. Neurology 56(12), 1712–1721 (2001). •• Seminal paper studying the occurrence of freezing of gait (FOG) in a large cohort of Parkinson's disease patients, providing robust informations about several factors associated to the onset and the severity of the phenomenon.
  Medline CASGoogle Scholar
• 21 Perez-Lloret S, Negre-Pages L, Damier P et al. Prevalence, determinants, and effect on quality of life of freezing of gait in Parkinson disease. JAMA Neurol. 71(7), 884–890 (2014).
  MedlineGoogle Scholar
• 22 Factor SA, Higgins DS, Qian J. Primary progressive freezing gait: a syndrome with many causes. Neurology 66(3), 411–414 (2006).
  MedlineGoogle Scholar
• 23 Schlenstedt C, Muthuraman M, Witt K, Weisser B, Fasano A, Deuschl G. Postural control and freezing of gait in Parkinson's disease. Parkinsonism. Relat. Disord. 24, 107–112 (2016).
  MedlineGoogle Scholar
• 24 Bartels AL, Balash Y, Gurevich T, Schaafsma JD, Hausdorff JM, Giladi N. Relationship between freezing of gait (FOG) and other features of Parkinson's: FOG is not correlated with bradykinesia. J. Clin. Neurosci. 10(5), 584–588 (2003).
  Medline CASGoogle Scholar
• 25 Wenning GK, Litvan I, Jankovic J et al. Natural history and survival of 14 patients with corticobasal degeneration confirmed at postmortem examination. J. Neurol. Neurosurg. Psychiatry 64(2), 184–189 (1998).
  Medline CASGoogle Scholar
• 26 Wenning GK, Ebersbach G, Verny M et al. Progression of falls in postmortem-confirmed parkinsonian disorders. Mov. Disord. 14(6), 947–950 (1999).
  Medline CASGoogle Scholar
• 27 Pinter B, Diem-Zangerl A, Wenning GK et al. Mortality in Parkinson's disease: a 38-year follow-up study. Mov. Disord. 30(2), 266–269 (2015).
  MedlineGoogle Scholar
• 28 Fasano A, Bloem BR. Gait disorders. Continuum (Minneap Minn) 19(5 Movement Disorders), 1344–1382 (2013).
  MedlineGoogle Scholar
• 29 Moreau C, Ozsancak C, Blatt JL, Derambure P, Destee A, Defebvre L. Oral festination in Parkinson's disease: biomechanical analysis and correlation with festination and freezing of gait. Mov. Disord. 22(10), 1503–1506 (2007).
  MedlineGoogle Scholar
• 30 Park HK, Yoo JY, Kwon M et al. Gait freezing and speech disturbance in Parkinson's disease. Neurol. Sci. 35(3), 357–363 (2014).
  Medline CASGoogle Scholar
• 31 Nieuwboer A, Vercruysse S, Feys P, Levin O, Spildooren J, Swinnen S. Upper limb movement interruptions are correlated to freezing of gait in Parkinson's disease. Eur. J. Neurosci. 29(7), 1422–1430 (2009).
  MedlineGoogle Scholar
• 32 Yanagisawa N, Hayashi R, Mitoma H. Pathophysiology of frozen gait in Parkinsonism. Adv. Neurol. 87, 199–207 (2001).
  Medline CASGoogle Scholar
• 33 Muller J, Seppi K, Stefanova N, Poewe W, Litvan I, Wenning GK. Freezing of gait in postmortem-confirmed atypical parkinsonism. Mov. Disord. 17(5), 1041–1045 (2002).
  MedlineGoogle Scholar
• 34 Bonnet AM, Loria Y, Saint-Hilaire MH, Lhermitte F, Agid Y. Does long-term aggravation of Parkinson's disease result from nondopaminergic lesions? Neurology 37(9), 1539–1542 (1987).
  Medline CASGoogle Scholar
• 35 Plotnik M, Hausdorff JM. The role of gait rhythmicity and bilateral coordination of stepping in the pathophysiology of freezing of gait in Parkinson's disease. Mov. Disord. 23(Suppl. 2), S444–S450 (2008).
  MedlineGoogle Scholar
• 36 Takakusaki K, Habaguchi T, Ohtinata-Sugimoto J, Saitoh K, Sakamoto T. Basal ganglia efferents to the brainstem centers controlling postural muscle tone and locomotion: a new concept for understanding motor disorders in basal ganglia dysfunction. Neuroscience 119(1), 293–308 (2003).
  Medline CASGoogle Scholar
• 37 Moore ST, Macdougall HG, Ondo WG. Ambulatory monitoring of freezing of gait in Parkinson's disease. J. Neurosci. Methods 167(2), 340–348 (2008).
  MedlineGoogle Scholar
• 38 Hausdorff JM, Schaafsma JD, Balash Y, Bartels AL, Gurevich T, Giladi N. Impaired regulation of stride variability in Parkinson's disease subjects with freezing of gait. Exp. Brain Res. 149(2), 187–194 (2003).
  Medline CASGoogle Scholar
• 39 Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Janssens L, Stijn V. Electromyographic profiles of gait prior to onset of freezing episodes in patients with Parkinson's disease. Brain 127(Pt 7), 1650–1660 (2004).
  MedlineGoogle Scholar
• 40 Nieuwboer A, Dom R, De Weerdt W, Desloovere K, Fieuws S, Broens-Kaucsik E. Abnormalities of the spatiotemporal characteristics of gait at the onset of freezing in Parkinson's disease. Mov. Disord. 16(6), 1066–1075 (2001).
  Medline CASGoogle Scholar
• 41 Cohen RG, Nutt JG, Horak FB. Errors in postural preparation lead to increased choice reaction times for step initiation in older adults. J. Gerontol. A Biol. Sci. Med. Sci. 66(6), 705–713 (2011).
  MedlineGoogle Scholar
• 42 Spildooren J, Vercruysse S, Heremans E et al. Head-pelvis coupling is increased during turning in patients with Parkinson's disease and freezing of gait. Mov. Disord. 28(5), 619–625 (2013).
  MedlineGoogle Scholar
• 43 Jacobs JV, Nutt JG, Carlson-Kuhta P, Stephens M, Horak FB. Knee trembling during freezing of gait represents multiple anticipatory postural adjustments. Exp. Neurol. 215(2), 334–341 (2009).
  MedlineGoogle Scholar
• 44 Schepens B, Stapley P, Drew T. Neurons in the pontomedullary reticular formation signal posture and movement both as an integrated behavior and independently. J. Neurophysiol. 100(4), 2235–2253 (2008).
  MedlineGoogle Scholar
• 45 Lewis SJ, Barker RA. A pathophysiological model of freezing of gait in Parkinson's disease. Parkinsonism Relat. Disord. 15(5), 333–338 (2009).
  MedlineGoogle Scholar
• 46 Holloway RG, Shoulson I, Fahn S et al. Pramipexole vs levodopa as initial treatment for Parkinson disease: a 4-year randomized controlled trial. Arch. Neurol. 61(7), 1044–1053 (2004).
  MedlineGoogle Scholar
• 47 Lewis SJ, Shine JM. The next step: a common neural mechanism for freezing of gait. Neuroscientist 22(1), 72–82 (2014).
  MedlineGoogle Scholar
• 48 Pahapill PA, Lozano AM. The pedunculopontine nucleus and Parkinson's disease. Brain 123(Pt 9), 1767–1783 (2000).
  MedlineGoogle Scholar
• 49 Giladi N, Treves TA, Simon ES et al. Freezing of gait in patients with advanced Parkinson's disease. J. Neural. Transm. 108(1), 53–61 (2001).
  Medline CASGoogle Scholar
• 50 Morita H, Hass CJ, Moro E, Sudhyadhom A, Kumar R, Okun MS. Pedunculopontine nucleus stimulation: where are we now and what needs to be done to move the field forward? Front. Neurol. 5, 243 (2014).
  MedlineGoogle Scholar
• 51 Almeida QJ, Lebold CA. Freezing of gait in Parkinson's disease: a perceptual cause for a motor impairment? J. Neurol. Neurosurg. Psychiatry 81(5), 513–518 (2010).
  Medline CASGoogle Scholar
• 52 Kostic VS, Agosta F, Pievani M et al. Pattern of brain tissue loss associated with freezing of gait in Parkinson disease. Neurology 78(6), 409–416 (2012).
  Medline CASGoogle Scholar
• 53 Herman T, Rosenberg-Katz K, Jacob Y, Giladi N, Hausdorff JM. Gray matter atrophy and freezing of gait in Parkinson's disease: is the evidence black-on-white? Mov. Disord. 29(1), 134–139 (2014).
  MedlineGoogle Scholar
• 54 Cowie D, Limousin P, Peters A, Day BL. Insights into the neural control of locomotion from walking through doorways in Parkinson's disease. Neuropsychologia 48(9), 2750–2757 (2010).
  MedlineGoogle Scholar
• 55 Naismith SL, Shine JM, Lewis SJ. The specific contributions of set-shifting to freezing of gait in Parkinson's disease. Mov. Disord. 25(8), 1000–1004 (2010).
  MedlineGoogle Scholar
• 56 Amboni M, Cozzolino A, Longo K, Picillo M, Barone P. Freezing of gait and executive functions in patients with Parkinson's disease. Mov. Disord. 23(3), 395–400 (2008).
  MedlineGoogle Scholar
• 57 Snijders AH, Leunissen I, Bakker M et al. Gait-related cerebral alterations in patients with Parkinson's disease with freezing of gait. Brain 134(Pt 1), 59–72 (2011).
  MedlineGoogle Scholar
• 58 Shine JM, Matar E, Ward PB et al. Differential neural activation patterns in patients with Parkinson's disease and freezing of gait in response to concurrent cognitive and motor load. PLoS ONE 8(1), e52602 (2013).
  Medline CASGoogle Scholar
• 59 Maidan I, Bernad-Elazari H, Gazit E, Giladi N, Hausdorff JM, Mirelman A. Changes in oxygenated hemoglobin link freezing of gait to frontal activation in patients with Parkinson disease: an fNIRS study of transient motor-cognitive failures. J. Neurol. 262(4), 899–908 (2015).
  Medline CASGoogle Scholar
• 60 Bohnen NI, Frey KA, Studenski S et al. Extra-nigral pathological conditions are common in Parkinson's disease with freezing of gait: an in vivo positron emission tomography study. Mov. Disord. 29(9), 1118–1124 (2014).
  Medline CASGoogle Scholar
• 61 Heremans E, Nieuwboer A, Vercruysse S. Freezing of gait in Parkinson's disease: where are we now? Curr. Neurol. Neurosci. Rep. 13(6), 350 (2013).
  MedlineGoogle Scholar
• 62 Alice N, Fabienne C, Anne-Marie W, Kaat D. Does freezing in Parkinson's disease change limb coordination? A kinematic analysis. J. Neurol. 254(9), 1268–1277 (2007).
  MedlineGoogle Scholar
• 63 Goetz CG, Tilley BC, Shaftman SR et al. Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): scale presentation and clinimetric testing results. Mov. Disord. 23(15), 2129–2170 (2008).
  MedlineGoogle Scholar
• 64 Giladi N, Tal J, Azulay T et al. Validation of the freezing of gait questionnaire in patients with Parkinson's disease. Mov. Disord. 24(5), 655–661 (2009). •• Validates the first questionnaire specifically developed to assess FOG.
  MedlineGoogle Scholar
• 65 Nieuwboer A, Rochester L, Herman T et al. Reliability of the new freezing of gait questionnaire: agreement between patients with Parkinson's disease and their carers. Gait Posture 30(4), 459–463 (2009).
  MedlineGoogle Scholar
• 66 Nieuwboer A, Giladi N. The challenge of evaluating freezing of gait in patients with Parkinson's disease. Br. J. Neurosurg. 22(Suppl. 1), S16–S18 (2008). • Highlights the importance to take advantage of combined diagnostic methodologies to properly assess FOG.
  MedlineGoogle Scholar
• 67 Rahman S, Griffin HJ, Quinn NP, Jahanshahi M. The factors that induce or overcome freezing of gait in Parkinson's disease. Behav. Neurol. 19(3), 127–136 (2008).
  Medline CASGoogle Scholar
• 68 Morris ME, Iansek R, Matyas TA, Summers JJ. Stride length regulation in Parkinson's disease. Normalization strategies and underlying mechanisms. Brain 119(Pt 2), 551–568 (1996).
  MedlineGoogle Scholar
• 69 Ziegler K, Schroeteler F, Ceballos-Baumann AO, Fietzek UM. A new rating instrument to assess festination and freezing gait in Parkinsonian patients. Mov. Disord. 25(8), 1012–1018 (2010).
  MedlineGoogle Scholar
• 70 Podsiadlo D, Richardson S. The timed ‘Up & Go’: a test of basic functional mobility for frail elderly persons. J. Am. Geriatr. Soc. 39(2), 142–148 (1991).
  Medline CASGoogle Scholar
• 71 Moe-Nilssen R, Aaslund MK, Hodt-Billington C, Helbostad JL. Gait variability measures may represent different constructs. Gait Posture 32(1), 98–101 (2010).
  MedlineGoogle Scholar
• 72 Weiss A, Herman T, Giladi N, Hausdorff JM. New evidence for gait abnormalities among Parkinson's disease patients who suffer from freezing of gait: insights using a body-fixed sensor worn for 3 days. J. Neural. Transm. 122(3), 403–410 (2014).
  MedlineGoogle Scholar
• 73 Horstink M, Tolosa E, Bonuccelli U et al. Review of the therapeutic management of Parkinson's disease. Report of a joint task force of the European Federation of Neurological Societies (EFNS) and the Movement Disorder Society-European Section (MDS-ES). Part II: late (complicated) Parkinson's disease. Eur. J. Neurol. 13(11), 1186–1202 (2006).
  Medline CASGoogle Scholar
• 74 Fahn S, Group PS. Does levodopa slow or hasten the rate of progression of Parkinson's disease? J. Neurol. 252(Suppl. 4), IV37–IV42 (2005).
  MedlineGoogle Scholar
• 75 Fahn S, Oakes D, Shoulson I et al. Levodopa and the progression of Parkinson's disease. N. Engl. J. Med. 351(24), 2498–2508 (2004).
  Medline CASGoogle Scholar
• 76 Giladi N. Medical treatment of freezing of gait. Mov. Disord. 23(Suppl. 2), S482–S488 (2008). •• A remarkably accurate overview on the currently available pharmacological strategies to address FOG.
  MedlineGoogle Scholar
• 77 Rascol O, Brooks DJ, Korczyn AD, De Deyn PP, Clarke CE, Lang AE. A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa. N. Engl. J. Med. 342(20), 1484–1491 (2000).
  Medline CASGoogle Scholar
• 78 Ahlskog JE, Muenter MD, Bailey PA, Stevens PM. Dopamine agonist treatment of fluctuating parkinsonism. D-2 (controlled-release MK-458) vs combined D-1 and D-2 (pergolide). Arch. Neurol. 49(5), 560–568 (1992).
  Medline CASGoogle Scholar
• 79 Shoulson I, Oakes D, Fahn S et al. Impact of sustained deprenyl (selegiline) in levodopa-treated Parkinson's disease: a randomized placebo-controlled extension of the deprenyl and tocopherol antioxidative therapy of parkinsonism trial. Ann. Neurol. 51(5), 604–612 (2002).
  Medline CASGoogle Scholar
• 80 Zuniga C, Lester J, Cersosimo MG, Diaz S, Micheli FE. Treatment of primary progressive freezing of gait with high doses of selegiline. Clin. Neuropharmacol. 29(1), 20–21 (2006).
  MedlineGoogle Scholar
• 81 Rascol O, Brooks DJ, Melamed E et al. Rasagiline as an adjunct to levodopa in patients with Parkinson's disease and motor fluctuations (LARGO, Lasting effect in Adjunct therapy with Rasagiline Given Once daily, study): a randomised, double-blind, parallel-group trial. Lancet 365(9463), 947–954 (2005).
  Medline CASGoogle Scholar
• 82 Uitti RJ, Rajput AH, Ahlskog JE et al. Amantadine treatment is an independent predictor of improved survival in Parkinson's disease. Neurology 46(6), 1551–1556 (1996).
  Medline CASGoogle Scholar
• 83 Inzelberg R, Bonuccelli U, Schechtman E et al. Association between amantadine and the onset of dementia in Parkinson's disease. Mov. Disord. 21(9), 1375–1379 (2006).
  MedlineGoogle Scholar
• 84 Macht M, Kaussner Y, Moller JC et al. Predictors of freezing in Parkinson's disease: a survey of 6620 patients. Mov. Disord. 22(7), 953–956 (2007).
  MedlineGoogle Scholar
• 85 Gurevich T, Peretz C, Moore O, Weizmann N, Giladi N. The effect of injecting botulinum toxin type a into the calf muscles on freezing of gait in Parkinson's disease: a double blind placebo-controlled pilot study. Mov. Disord. 22(6), 880–883 (2007).
  MedlineGoogle Scholar
• 86 Wieler M, Camicioli R, Jones CA, Martin WR. Botulinum toxin injections do not improve freezing of gait in Parkinson disease. Neurology 65(4), 626–628 (2005).
  Medline CASGoogle Scholar
• 87 Narabayashi H, Yokochi F, Ogawa T, Igakura T. Analysis of L-threo-3, 4-dihydroxyphenylserine effect on motor and psychological symptoms in Parkinson's disease. No To Shinkei 43(3), 263–268 (1991).
  Medline CASGoogle Scholar
• 88 Fukada K, Endo T, Yokoe M, Hamasaki T, Hazama T, Sakoda S. L-threo-3, 4-dihydroxyphenylserine (L-DOPS) co-administered with entacapone improves freezing of gait in Parkinson's disease. Med. Hypotheses 80(2), 209–212 (2013).
  Medline CASGoogle Scholar
• 89 Auriel E, Hausdorff JM, Herman T, Simon ES, Giladi N. Effects of methylphenidate on cognitive function and gait in patients with Parkinson's disease: a pilot study. Clin. Neuropharmacol. 29(1), 15–17 (2006).
  Medline CASGoogle Scholar
• 90 Espay AJ, Dwivedi AK, Payne M et al. Methylphenidate for gait impairment in Parkinsondisease: a randomized clinical trial. Neurology 76(14), 1256–1262 (2011).
  Medline CASGoogle Scholar
• 91 Henderson EJ, Lord SR, Brodie MA et al. Rivastigmine for gait stability in patients with Parkinson's disease (ReSPonD): a randomised, double-blind, placebo-controlled, Phase 2 trial. Lancet Neurol. 15(3), 249–258 (2016).
  Medline CASGoogle Scholar
• 92 Yener GG, Kaya GC, Ozturk V, Akdal G. Improvement in Tc-99m HMPAO brain SPECT findings during donepezil therapy in a patient with pure akinesia. Ann. Nucl. Med. 19(7), 607–609 (2005).
  MedlineGoogle Scholar
• 93 Morris ME, Martin CL, Schenkman ML. Striding out with Parkinson disease: evidence-based physical therapy for gait disorders. Phys. Ther. 90(2), 280–288 (2010).
  MedlineGoogle Scholar
• 94 Dibble LE, Addison O, Papa E. The effects of exercise on balance in persons with Parkinson's disease: a systematic review across the disability spectrum. J. Neurol. Phys. Ther. 33(1), 14–26 (2009).
  MedlineGoogle Scholar
• 95 Lo AC, Chang VC, Gianfrancesco MA, Friedman JH, Patterson TS, Benedicto DF. Reduction of freezing of gait in Parkinson's disease by repetitive robot-assisted treadmill training: a pilot study. J. Neuroeng. Rehabil. 7, 51 (2010).
  MedlineGoogle Scholar
• 96 Hong M, Earhart GM. Rotating treadmill training reduces freezing in Parkinson disease: preliminary observations. Parkinsonism. Relat. Disord. 14(4), 359–363 (2008).
  MedlineGoogle Scholar
• 97 Curra A, Berardelli A, Agostino R et al. Performance of sequential arm movements with and without advance knowledge of motor pathways in Parkinson's disease. Mov. Disord. 12(5), 646–654 (1997).
  Medline CASGoogle Scholar
• 98 Okuma Y. Freezing of gait in Parkinson's disease. J. Neurol. 253(Suppl. 7), Vii27–Vii32 (2006).
  MedlineGoogle Scholar
• 99 Morris ME. Movement disorders in people with Parkinson disease: a model for physical therapy. Phys. Ther. 80(6), 578–597 (2000).
  Medline CASGoogle Scholar
• 100 Frazzitta G, Maestri R, Uccellini D, Bertotti G, Abelli P. Rehabilitation treatment of gait in patients with Parkinson's disease with freezing: a comparison between two physical therapy protocols using visual and auditory cues with or without treadmill training. Mov. Disord. 24(8), 1139–1143 (2009).
  MedlineGoogle Scholar
• 101 Martin T, Weatherall M, Anderson TJ, Macaskill MR. A randomized controlled feasibility trial of a specific cueing program for falls management in persons with Parkinson disease and freezing of gait. J. Neurol. Phys. Ther. 39(3), 179–184 (2015).
  MedlineGoogle Scholar
• 102 Okun MS, Foote KD. Parkinson's disease DBS: what, when, who and why? The time has come to tailor DBS targets. Expert Rev. Neurother. 10(12), 1847–1857 (2010).
  MedlineGoogle Scholar
• 103 Russmann H, Ghika J, Villemure JG et al. Subthalamic nucleus deep brain stimulation in Parkinson disease patients over age 70 years. Neurology 63(10), 1952–1954 (2004).
  Medline CASGoogle Scholar
• 104 Umemura A, Oka Y, Okita K, Toyoda T, Matsukawa N, Yamada K. Predictive factors affecting early deterioration of axial symptoms after subthalamic nucleus stimulation in Parkinson's disease. Parkinsonism Relat. Disord. 16(9), 582–584 (2010).
  MedlineGoogle Scholar
• 105 Weaver FM, Follett K, Stern M et al. Bilateral deep brain stimulation vs best medical therapy for patients with advanced Parkinson disease: a randomized controlled trial. JAMA 301(1), 63–73 (2009).
  Medline CASGoogle Scholar
• 106 Limousin P, Krack P, Pollak P et al. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease. N. Engl. J. Med. 339(16), 1105–1111 (1998).
  Medline CASGoogle Scholar
• 107 Xie T, Vigil J, Maccracken E et al. Low-frequency stimulation of STN-DBS reduces aspiration and freezing of gait in patients with PD. Neurology 84(4), 415–420 (2015).
  MedlineGoogle Scholar
• 108 Yokoyama T, Sugiyama K, Nishizawa S, Yokota N, Ohta S, Uemura K. Subthalamic nucleus stimulation for gait disturbance in Parkinson's disease. Neurosurgery 45(1), 41–47; discussion 47–49 (1999).
  Medline CASGoogle Scholar
• 109 Ferraye MU, Debu B, Fraix V et al. Effects of pedunculopontine nucleus area stimulation on gait disorders in Parkinson's disease. Brain 133(Pt 1), 205–214 (2010).
  Medline CASGoogle Scholar
• 110 Moro E, Hamani C, Poon YY et al. Unilateral pedunculopontine stimulation improves falls in Parkinson's disease. Brain 133(Pt 1), 215–224 (2010).
  MedlineGoogle Scholar
• 111 Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int. J. Neuropsychopharmacol. 14(8), 1133–1145 (2011).
  MedlineGoogle Scholar
• 112 Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin. Neurophysiol. 120(12), 2008–2039 (2009).
  MedlineGoogle Scholar
• 113 Fregni F, Simon DK, Wu A, Pascual-Leone A. Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature. J. Neurol. Neurosurg. Psychiatry 76(12), 1614–1623 (2005).
  Medline CASGoogle Scholar
• 114 Wu AD, Fregni F, Simon DK, Deblieck C, Pascual-Leone A. Noninvasive brain stimulation for Parkinson's disease and dystonia. Neurotherapeutics 5(2), 345–361 (2008).
  MedlineGoogle Scholar
• 115 Kamble N, Netravathi M, Pal PK. Therapeutic applications of repetitive transcranial magnetic stimulation (rTMS) in movement disorders: a review. Parkinsonism Relat. Disord. 20(7), 695–707 (2014).
  MedlineGoogle Scholar
• 116 Nitsche MA, Cohen LG, Wassermann EM et al. Transcranial direct current stimulation: state of the art 2008. Brain Stimul. 1(3), 206–223 (2008).
  MedlineGoogle Scholar
• 117 Rektorova I, Sedlackova S, Telecka S, Hlubocky A, Rektor I. Repetitive transcranial stimulation for freezing of gait in Parkinson's disease. Mov. Disord. 22(10), 1518–1519 (2007).
  MedlineGoogle Scholar
• 118 Lee SY, Kim MS, Chang WH, Cho JW, Youn JY, Kim YH. Effects of repetitive transcranial magnetic stimulation on freezing of gait in patients with Parkinsonism. Restor. Neurol. Neurosci. 32(6), 743–753 (2014).
  MedlineGoogle Scholar
• 119 Kim MS, Hyuk Chang W, Cho JW et al. Efficacy of cumulative high-frequency rTMS on freezing of gait in Parkinson's disease. Restor. Neurol. Neurosci. 33(4), 521–530 (2015).
  MedlineGoogle Scholar
• 120 Valentino F, Cosentino G, Brighina F et al. Transcranial direct current stimulation for treatment of freezing of gait: a cross-over study. Mov. Disord. 29(8), 1064–1069 (2014).
  MedlineGoogle Scholar
• 121 Elahi B, Elahi B, Chen R. Effect of transcranial magnetic stimulation on Parkinson motor function-systematic review of controlled clinical trials. Mov. Disord. 24(3), 357–363 (2009).
  MedlineGoogle Scholar
• 122 Chou YH, Hickey PT, Sundman M, Song AW, Chen NK. Effects of repetitive transcranial magnetic stimulation on motor symptoms in Parkinson disease: a systematic review and meta-analysis. JAMA Neurol. 72(4), 432–440 (2015).
  MedlineGoogle Scholar
• 123 Vonloh M, Chen R, Kluger B. Safety of transcranial magnetic stimulation in Parkinson's disease: a review of the literature. Parkinsonism Relat. Disord. 19(6), 573–585 (2013).
  MedlineGoogle Scholar
• 124 Brunoni AR, Nitsche MA, Bolognini N et al. Clinical research with transcranial direct current stimulation (tDCS): challenges and future directions. Brain Stimul. 5(3), 175–195 (2012).
  MedlineGoogle Scholar
• 125 Wagner T, Valero-Cabre A, Pascual-Leone A. Noninvasive human brain stimulation. Annu. Rev. Biomed. Eng. 9, 527–565 (2007).
  Medline CASGoogle Scholar
• 126 Brunoni AR, Fregni F. Clinical trial design in non-invasive brain stimulation psychiatric research. Int. J. Methods Psychiatr. Res. 20(2), e19–e30 (2011).
  MedlineGoogle Scholar
• 127 Bikson M, Grossman P, Thomas C et al. Safety of transcranial direct current stimulation: evidence based update 2016. Brain Stimul. doi:10.1016/j.brs.2016.06.004 (2016) (Epub ahead of print).
  Google Scholar